The self-assembly of proteins into amyloid is an initiating step in misfolding 1,2 and infectious prion 3 diseases. The process is traditionally described as a thermodynamically-driven "ripening" of accessible conformations and the range of phases that exist under a given set of conditions is the result of amyloid polymorphism. Recently, secondary nucleation sites 4, 5 have suggested the possibility of a more progressive pathway contributing to different assembled phases. Here we experimentally demonstrate the minimal nucleating core 6,7 of the Dutch mutant 8 of the A peptide of Alzheimer's disease (AD), Aβ(16-22)E22Q or Ac -16 KLVFFA22Q-NH 2 , assembles as anti-parallel -strands that later transition completely into parallel arrays. These studies define a progressive pathway for amyloid assembly, even for simple model peptides, and reveal new mechanisms for achieving polymorphic diversity in disease etiology. 
Simulation
9-14 and emperical [15] [16] [17] [18] [19] [20] [21] [22] analyses of assembly are consistent with an initial solvation free energydriven oligomerization to a particle phase. We reasoned secondary structure formation within the less hydrated peptide particle phase [22] [23] [24] 19 Electrostatic repulsion between lysine side chains would select against charged N-terminal lysine residue proximity in parallel strands ( Fig. 1 ) during nucleation.
Given that anti-parallel out-of-register alignment in Aβ(16-22)E22L is directed by the preference of the bulky valine side chain at position 18 being across (cross-strand pairing) from the less bulky alanine , 19, 20 we hypothesized that uncharged substitutions would stabilize different strand arrangements. Structural 25, 26 and thermodynamic 27 investigations have identified ordered glutamine side chains in cross-strand stabilization of parallel registries, and the Dutch mutant of Aβ 8 manifested as the Aβ(16-22)E22Q congener which conservatively swaps a side chain -OH for an -NH 2 , appeared suitable to change the energy balance. Quite distinct from previous cytosine substitution 28 or metal ion binding elements which stabilize sheet stacking interactions 29 , the E22Q substitution could stabilize parallel strand registry through cross-strand pairing via amide side-chain H-bonding. C coupling is most diagnostic of β-strand registry 19, 30, 31 , shows a band splitting 19,31-34 of almost 40 cm -1 and a 12 C/ 13 C band intensity ratio of less than 1 (Fig 2C, black, S2 ). These assignments are consistent with previously characterized assemblies 30, 31, [33] [34] [35] [36] [37] , and define one-residue out-of-register antiparallel stranded β-sheets (Fig 1) . However, these assemblies do not persist. Approximately one week after assembly is initiated the FT-IR spectra begins a cooperative transition into long smooth fibers that after 20 days have diameters of 11.6 ± 1.2 nm (Fig. 2B,S3 ). Changes in the frequency and amplitude of the 12 C/ 13 C amide-I bands (Fig. 2D, S4 ) track with the morphological transitions seen by EM. A CO stretch at 1677 cm -1 assigned to ordered glutamine side chains 38,39 grew with the transition. The final assemblies with circular dichroism ellipticity minimum at 217 nm ( Fig S5) and X-ray powder diffraction (Fig. S6 ) d-spacing reflections at 4.76 Å and 10.1 Å are typical of cross-β assemblies.
19
The orientation and specific registry of each Aβ(16-22)E22Q strand is defined via the rate of double-quantum coherence build-up through homonuclear dipolar coupling in 13 C DQF-DRAWS 40 solid-state NMR experiments. Using the infinite array approximation 28, 41, 42 (Fig S7) , and including the effects of double quantum relaxation 41 , T 2 DQ = 11.7ms (Fig S8) , the build-up of [1-
13 C]-L17 intensity from enriched E22Q assemblies uniquely fits a parallel in-register strand arrangement (Fig. 3B, S9 ). These analyses do not support the glutamine/inter-sheet H-bonding (Q-tracks) prevalent in Huntington's inserts 26 , as they require laminate spacings 43 of 8 Å for backbone to side chain H-bonding rather than the 10.1 Å spacing seen in these assemblies. These data, together with the glutamine side chain CO stretch at 1677 cm -1 (Fig. 2C, red) , are consistent with cross-strand pairing along the sheet surface through extended side chain H-bonding Q-tracks as shown in Fig. 3C . (Table S1 & Fig S10D) support the same one-residue out-ofregister antiparallel β-strands. Unlike Aβ(16-22)E22Q, no distinct IR band at 1677 cm -1 diagnostic for ordered glutamine sidechains is apparent in the N 5 ,N 5 -dimethylated glutamine peptide assemblies. In contrast, the mono-methylated Aβ(16-22)E22QNHCH 3 peptide assembles as fibril bundles (Fig S10B) with individual widths ranging from 7 nm in a single fiber to bundles containing up to five twisted fibers (Fig S11) . Time-dependent IR spectra of assembling [1-
13 C]F19 enriched monomethyl peptides (Fig S12) reveals a similar early antiparallel orientation that also transitions to parallel with growth of the glutamine side chain band at 1677 cm -1 , but the spectra are most consistent with the mature assemblies containing a mixture of parallel, antiparallel in-register, and antiparallel out-of-register assemblies (Fig S12, inset) . Monomethylation appears to weaken the extended glutamine side chain H-bonding Q-track, and is expected to create a methylated surface. We predict that mixed fibers, or even mixed domains within individual fibers, are responsible for the bundling. These data argue that the nucleating core of the Aβ peptide of AD follows an obligatory hydrophobic collapse to intermolecular molten particles. [22] [23] [24] The E22Q substitution provides an energetic constraint sufficient for a new transition, and one that does not manifest in the molten particle phase. The addition of 1% by weight pre-assembled fibers prepared from mature parallel E22Q assemblies complete the transition to parallel strands within hours (Fig 4, S13) . Once initiated, parallel strand assembly propagates quickly, establishing the propagation of parallel strands is not limiting. Simulations of propagation find that the growing fiber ends can accept strands with altered orientations, 13 and in the aqueous environment on a template where lysine side-chain repulsion may be attenuated and cross-strand pairing to a pre-organized glutamine side-chain stabilizing (Fig. 3C) , conformational "mutations" could accumulate as stabilized by extended glutamine side chain H-bonded Q-tracks. After a certain parallel concentration threshold is reached, fibril fragmentation of mutation-rich domains would generate new parallel ends and grow autocatalytically. This mechanism makes several predictions, which can now be explored through experimentation and simulation. Other mechanistic models, including the glutamine-rich C-termini exposed along the length of the fibril (Fig 5) serving as a secondary nucleation site, 4,5 need also to be explored.
Like many materials, 44 these minimal amyloid peptides experience the competing tensions of thermodynamicallycontrolled growth and kinetic nucleation, but amyloid assemblies have also been implicated in disease evolution. 2, [45] [46] [47] While the larger disease relevant peptides certainly have greater potential for kinetic and thermodynamic conformational diversity, their assembly is also expected to be even more diversified by the complex fluid 48 environment of the eukaryotic cell. The conformational evolution seen in disease likely follows a progressive and irreversible path, and any of these kinetically accessible phases 49 could be nucleated and stabilized by the cellular matrix for a Darwinian-like diversification and selection. 2, 45, 50 Reconsideration of the confounding determinants required for a conformational evolution in the cell could open new strategies for defining and diverting disease-relevant assemblies for therapeutic intervention.
